🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Amazing atlas for polymyalgia rheumatica made by David Liew Claire Owen and colleagues Full text available Rheumatology & Rheumatology Advances in Practice BSR #polymyalgia #PETCT bit.ly/3w0XC4G

Important reading about devices (including algorithms) used for health measurement or prediction: Whitehead review on equity in medical devices. Much to ponder. liverpool.ac.uk/research/resea…

Glucocorticoids (GC), like dexamethasone and prednisolone, are widely used in medicine, but how do they actually work? This is really impressive work (Auger et al.), which figured it all out There are two mechanisms: a slow, broad response, which depends on transcriptional

An investigation of fibroblast activation protein (FAP) in giant cell arteritis found FAP was abundantly expressed by fibroblasts in GCA arteries FAP may be involved in the inflammatory and remodeling processes in GCA In AC&R loom.ly/PAKK4lY @VasculitisUMCG

Been thinking about this lovely episode of Casual Inference Podcast in which @lucystats and @epiellie talk to Aaditya Ramdas about sequential/safe anytime-valid inference. podcasts.apple.com/gb/podcast/cas… Here’s what I took away from the podcast episode, thinking mostly about #clinicaltrials (hope

Inspired by our last Annual Conference? Want to help shape the biggest rheumatology event of 2025? In the clip below 🩺 Dr Max Yates outlines the benefits of submitting a session and shares advice on impactful content! Submit a #BSR25 session by 3 June: bit.ly/4bGFX1N

Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomisation academic.oup.com/rheumatology/a…

PMR patients get too much steroid. Data across 27 million people in England, n=39,438 with PMR. The blue are getting more pred than guidelines. Like everything in rheum: we need to be giving less pred, not more. Lumping PMR in with GCA won’t help. #EULAR2024 POS0411 Dr. John Cush

Rheumatologists see a different part of the #GiantCellArteritis #GCA spectrum than ophthalmologists. What does this mean for diagnosis, treatment and care? Read this review in full #OpenAccess here: nature.com/articles/s4143… Sarah Mackie #Ophthalmology #FOAMed

🚨Largest GWAS of #PolymyalgiaRheumatica to date finds 3 new loci: -IL1R1 -NEK6 -CCDC88B 🚨MR shows associations between: -Smoking -Visceral adiposity -Multiple proteins relevant to IL-1 signalling and #PMR risk Rheumatology & Rheumatology Advances in Practice Sarah Mackie Shuai Yuan 袁帅 academic.oup.com/rheumatology/a…

Our recent review on the spectrum of giant cell arteritis: part of special issue of Eye Dr Susan Mollan #giantcellarteritis #GCA #PMR #FOAMed BSR NIHR Leeds BRC Borsha kate smith Vanessa Quick Khalique, M.I., Arjunan, M., Wood, S. et al. The spectrum of giant cell

Dr Aruna Chakrabarty, Neuropathologist at Leeds Teaching Hospitals speaking about the impact of the Leeds GCA pathway from her perspective and the value of multi-speciality collaboration

🚀Join the #EULAR - Educational Webinar Series: "GCA: what is new?" 💻Wednesday, 30 October 2024, 18:00-18:45 CET Register here👉pulse.ly/wm4w23zdtr EULAR

Our first RCT on using an LLM on diagnostic reasoning is out! And the results are 🔥🌶️... adding ChatGPT did NOT improve diagnostic accuracy or reasoning, and the AI alone outperformed ALL the humans. What does this mean? A 🧵⬇️ x.com/EricTopol/stat…

The #FHJDebate: Will #artificialintelligence replace clinical decision making within our lifetimes? Read the article here 👇 sciencedirect.com/science/articl… Vote here 👇 forms.office.com/e/eeHsZfa6vz

The #SudlowReview marks a significant step towards making health data work better for the UK. Strong, trustworthy data systems - designed with patients, researchers & healthcare providers - will lead to better care & treatment. Read more 👇 acmedsci.ac.uk/more/news/sudl…

Had lovely feedback from a rheumatology consultant about the Leeds GCA course we ran in Sept: “I’ve strongly recommended the Leeds course, it was amongst the best teaching I’ve attended.” It’s really nice to have this feedback and to be able to share it with the team here!

JAK inhibitors in GCA? We have a phase 3 trial in giant cell arteritis back on the opening day plenary stage. The SELECT-GCA study, looking at upadacitinib in GCA, was scheduled to anchor the #ACR24 opening plenary for a reason - it is highly notable and badly needed.

Join us for the next episode in the specialty series on Tuesday 18 February at 6.30pm! Our panel Rachel Tattersall, Sarah Mackie and Toby Maher will discuss key updates in rheumatology. Followed by a question and answer session. Book your place now: ow.ly/cLri50UXRCi